Macrocyclic peptoid-peptide hybrids as inhibitors of class I histone deacetylases

ACS Medicinal Chemistry Letters

Volumn 3, Issue 9, 2012, Pages 749-753

  Olsen, Christian A ^a   Montero, Ana ^a   Leman, Luke J ^a   Ghadiri, M Reza ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

apicidin; HDAC inhibitors; macrocycles; peptides; peptoids

Indexed keywords

APICIDIN; HISTONE DEACETYLASE INHIBITOR; PEPTIDE DERIVATIVE; PEPTOID;

ARTICLE; CELL STRAIN K 562; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DESIGN; DRUG POTENCY; DRUG SELECTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; LEUKEMIA CELL LINE; PRIORITY JOURNAL;

EID: 84866367304     PISSN: None     EISSN: 19485875     Source Type: Journal    
DOI: 10.1021/ml300162r     Document Type: Article

References (41)

1. Montero, A.; Beierle, J. M.; Olsen, C. A.; Ghadiri, M. R. Design, synthesis, biological evaluation, and structural characterization of potent histone deacetylase inhibitors based on cyclic alpha/beta-tetrapeptide architectures J. Am. Chem. Soc. 2009, 131, 3033-3041
2. Olsen, C. A.; Ghadiri, M. R. Discovery of potent and selective histone deacetylase inhibitors via focused combinatorial libraries of cyclic alpha3beta-tetrapeptides J. Med. Chem. 2009, 52, 7836-7846
3. Horne, W. S.; Olsen, C. A.; Beierle, J. M.; Montero, A.; Ghadiri, M. R. Probing the bioactive conformation of an archetypal natural product HDAC inhibitor with conformationally homogeneous triazole-modified cyclic tetrapeptides Angew. Chem., Int. Ed. 2009, 48, 4718-4724
4. Beierle, J. M.; Horne, W. S.; van Maarseveen, J. H.; Waser, B.; Reubi, J. C.; Ghadiri, M. R. Conformationally homogeneous heterocyclic pseudotetrapeptides as three-dimensional scaffolds for rational drug design: receptor-selective somatostatin analogues Angew. Chem., Int. Ed. 2009, 48, 4725-4729
5. Hutt, D. M.; Olsen, C. A.; Vickers, C. J.; Herman, D.; Chalfant, M.; Montero, A.; Leman, L. J.; Burkle, R.; Maryanoff, B. E.; Balch, W. E.; Ghadiri, M. R. Potential agents for treating cystic fibrosis: Cyclic tetrapeptides that restore trafficking and activity of DeltaF508-CFTR ACS Med. Chem. Lett. 2011, 2, 703-707
6. Vickers, C. J.; Olsen, C. A.; Leman, L. J.; Ghadiri, M. R. Discovery of HDAC inhibitors that lack an active site Zn2+-binding functional group ACS Med. Chem. Lett. 2012, 3, 505-508
7. Paris, M.; Porcelloni, M.; Binaschi, M.; Fattori, D. Histone deacetylase inhibitors: from bench to clinic J. Med. Chem. 2008, 51, 1505-1529
8. Minucci, S.; Pelicci, P. G. Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer Nat. Rev. Cancer 2006, 6, 38-51
9. Bolden, J. E.; Peart, M. J.; Johnstone, R. W. Anticancer activities of histone deacetylase inhibitors Nat. Rev. Drug Discov. 2006, 5, 769-784
10. Marks, P. A.; Breslow, R. Dimethyl sulfoxide to vorinostat: development of this histone deacetylase inhibitor as an anticancer drug Nat. Biotechnol. 2007, 25, 84-90
11. Furumai, R.; Matsuyama, A.; Kobashi, N.; Lee, K. H.; Nishiyama, M.; Nakajima, H.; Tanaka, A.; Komatsu, Y.; Nishino, N.; Yoshida, M.; Horinouchi, S. FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases Cancer Res. 2002, 62, 4916-4921
12. Darkin-Rattray, S. J.; Gurnett, A. M.; Myers, R. W.; Dulski, P. M.; Crumley, T. M.; Allocco, J. J.; Cannova, C.; Meinke, P. T.; Colletti, S. L.; Bednarek, M. A.; Singh, S. B.; Goetz, M. A.; Dombrowski, A. W.; Polishook, J. D.; Schmatz, D. M. Apicidin: a novel antiprotozoal agent that inhibits parasite histone deacetylase Proc. Natl. Acad. Sci. U. S. A. 1996, 93, 13143-13147
13. Bertrand, P. Inside HDAC with HDAC inhibitors Eur. J. Med. Chem. 2010, 45, 2095-2116
14. Biel, M.; Wascholowski, V.; Giannis, A. Epigenetics - an epicenter of gene regulation: histones and histone-modifying enzymes Angew. Chem., Int. Ed. 2005, 44, 3186-3216
15. Zuckermann, R. N.; Kodadek, T. Peptoids as potential therapeutics Curr. Opin. Mol. Ther. 2009, 11, 299-307
16. Simon, R. J.; Kania, R. S.; Zuckermann, R. N.; Huebner, V. D.; Jewell, D. A.; Banville, S.; Ng, S.; Wang, L.; Rosenberg, S.; Marlowe, C. K. Peptoids: a modular approach to drug discovery Proc. Natl. Acad. Sci. U. S. A. 1992, 89, 9367-9371
17. Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. H.; Moos, W. H. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis J. Am. Chem. Soc. 1992, 114, 10646-10647
18. Nguyen, J. T.; Turck, C. W.; Cohen, F. E.; Zuckermann, R. N.; Lim, W. A. Exploiting the basis of proline recognition by SH3 and WW domains: design of N-substituted inhibitors Science 1998, 282, 2088-2092
19. Hara, T.; Durell, S. R.; Myers, M. C.; Appella, D. H. Probing the structural requirements of peptoids that inhibit HDM2-p53 interactions J. Am. Chem. Soc. 2006, 128, 1995-2004
20. Udugamasooriya, D. G.; Dineen, S. P.; Brekken, R. A.; Kodadek, T. A peptoid "antibody surrogate" that antagonizes VEGF receptor 2 activity J. Am. Chem. Soc. 2008, 130, 5744-5752
21. Chongsiriwatana, N. P.; Patch, J. A.; Czyzewski, A. M.; Dohm, M. T.; Ivankin, A.; Gidalevitz, D.; Zuckermann, R. N.; Barron, A. E. Peptoids that mimic the structure, function, and mechanism of helical antimicrobial peptides Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 2794-2799
22. Fowler, S. A.; Stacy, D. M.; Blackwell, H. E. Design and synthesis of macrocyclic peptomers as mimics of a quorum sensing signal from Staphylococcus aureus Org. Lett. 2008, 10, 2329-2332
23. Levine, P. M.; Imberg, K.; Garabedian, M. J.; Kirshenbaum, K. Multivalent peptidomimetic conjugates: a versatile platform for modulating androgen receptor activity J. Am. Chem. Soc. 2012, 134, 6912-6915
24. Comegna, D.; Benincasa, M.; Gennaro, R.; Izzo, I.; De Riccardis, F. Design, synthesis and antimicrobial properties of non-hemolytic cationic alpha-cyclopeptoids Bioorg. Med. Chem. 2010, 18, 2010-2018
25. Huang, M. L.; Shin, S. B.; Benson, M. A.; Torres, V. J.; Kirshenbaum, K. A comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents ChemMedChem 2012, 7, 114-122
26. Demmer, O.; Frank, A. O.; Hagn, F.; Schottelius, M.; Marinelli, L.; Cosconati, S.; Brack-Werner, R.; Kremb, S.; Wester, H. J.; Kessler, H. A Conformationally Frozen Peptoid Boosts CXCR4 Affinity and Anti-HIV Activity Angew. Chem., Int. Ed. Engl. 2012, 51, 8110-8113
27. Olsen, C. A. Peptoid-Peptide hybrid backbone architectures ChemBioChem 2010, 11, 152-160
28. Olsen, C. A.; Ziegler, H. L.; Nielsen, H. M.; Frimodt-Moller, N.; Jaroszewski, J. W.; Franzyk, H. Antimicrobial, hemolytic, and cytotoxic activities of beta-peptoid-peptide hybrid oligomers: improved properties compared to natural AMPs ChemBioChem 2010, 11, 1356-1360
29. Olsen, C. A.; Bonke, G.; Vedel, L.; Adsersen, A.; Witt, M.; Franzyk, H.; Jaroszewski, J. W. Alpha-peptide/beta-peptoid chimeras Org. Lett. 2007, 9, 1549-1552
30. Vedel, L.; Bonke, G.; Foged, C.; Ziegler, H.; Franzyk, H.; Jaroszewski, J. W.; Olsen, C. A. Antiplasmodial and prehemolytic activities of alpha-peptide-beta-peptoid chimeras ChemBioChem 2007, 8, 1781-1784
31. Shuey, S. W.; Delaney, W. J.; Shah, M. C.; Scialdone, M. A. Antimicrobial beta-peptoids by a block synthesis approach Bioorg. Med. Chem. Lett. 2006, 16, 1245-1248
32. Shin, S. B.; Yoo, B.; Todaro, L. J.; Kirshenbaum, K. Cyclic peptoids J. Am. Chem. Soc. 2007, 129, 3218-3225
33. Roy, O.; Faure, S.; Thery, V.; Didierjean, C.; Taillefumier, C. Cyclic beta-peptoids Org. Lett. 2008, 10, 921-924
34. Stringer, J. R.; Crapster, J. A.; Guzei, I. A.; Blackwell, H. E. Extraordinarily robust polyproline type I peptoid helices generated via the incorporation of alpha-chiral aromatic N-1-naphthylethyl side chains J. Am. Chem. Soc. 2011, 133, 15559-15567
35. Caumes, C.; Roy, O.; Faure, S.; Taillefumier, C. The click triazolium peptoid side chain: a strong cis-amide inducer enabling chemical diversity J. Am. Chem. Soc. 2012, 134, 9553-9556
36. White, C. J.; Yudin, A. K. Contemporary strategies for peptide macrocyclization Nat. Chem. 2011, 3, 509-524
37. Kranz, M.; Murray, P. J.; Taylor, S.; Upton, R. J.; Clegg, W.; Elsegood, M. R. J. Solution, solid phase and computational structures of apicidin and its backbone-reduced analogs J. Pept. Sci. 2006, 12, 383-388
38. Bradner, J. E.; West, N.; Grachan, M. L.; Greenberg, E. F.; Haggarty, S. J.; Warnow, T.; Mazitschek, R. Chemical phylogenetics of histone deacetylases Nat. Chem. Biol. 2010, 6, 238-243
39. Jones, P.; Steinkuhler, C. From natural products to small molecule ketone histone deacetylase inhibitors: development of new class specific agents Curr. Pharm. Des. 2008, 14, 545-561
40. Gregoretti, I. V.; Lee, Y. M.; Goodson, H. V. Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis J. Mol. Biol. 2004, 338, 17-31
41. Gurard-Levin, Z. A.; Mrksich, M. The activity of HDAC8 depends on local and distal sequences of its peptide substrates Biochemistry 2008, 47, 6242-6250